Related Experiment Video
Updated: May 31, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
[What strategy for the screening of coronary artery disease in type 1 diabetes?]
1Service d'endocrinologie, diabétologie et métabolisme, CHUV, 1011 Lausanne. sophie.comte@chuv.ch
Abstract:
Screening benefits for silent coronary artery disease in type 2 diabetes patients has been recently questioned following the publication of the DIAD study. For type 1 diabetes, there are no specific screening recommendations. For these patients, duration of the disease and microvascular complications are to be taken into account in assessing the risk of coronary artery disease. Intensive glycemic control reduces cardiovascular mortality. Other cardiovascular risk factors are also to be taken into consideration in assessing coronary risk, and should also be treated aggressively. Given the lack of prospective studies evaluating screening benefit for silent coronary artery disease in type 1 diabetes patients, screening strategies should be assessed depending on the context.
Related Concept Videos
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
